Newstral.com: “A Cable Bull Goes Neutral on the Stocks. Here’s Why.”
Birnbach Communications’ Top Predictions for 2014, Part VII: Ongoing News Stories
Grant Welker on Twitter: “The biotech firm LakePharma has signed a partnership agreement with a North Shore therapeutics company to jointly develop a potential COVID-19 vaccine at its Hopkinton facility”
Media Predictions & the Speed of Change + One Prediction We Did Not Get Completely Right. Ok, More than Not Right
Canton Community TV: “In The Spotlight: The MIND Diet”
Birnbach Communications’ Top Predictions for 2014, Part VI: General News Stories
When is a link not a link?
Birnbach Communications’ Top Predictions for 2014, Part V: Ongoing Consumer Trends
CommPro.Biz: “9 Media Trends for 2022: Supply Chain, Healthcare, Infrastructure, HR, the Future of Money, and Cybersecurity Will Dominate the Media Landscape”
Contract Pharma: “Akston Biosciences, Seppic Ink Commercial Supply Agreement: Deal is for an adjuvant to formulate shelf-stable COVID-19 vaccine at global scale”
Canton Citizen: “Canton residents awarded scholarships from Hebrew SeniorLife communities”
RepublicWorld.com (India): “Akston Biosciences Launches Phase I/II Clinical Trial Of Second-Generation COVID-19 Vaccine: Akston Biosciences Corporation, a developer of new classes of biologic therapeutics, announced today that the first participants have been dosed in an open-label trial of AKS-452, its COVID-19 vaccine candidate”